Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.
Log in to post a reply
Jul 15, 2021 08:41PM
I am so sorry that you’re having to deal with this again. I don’t have the experience to answer your questions, but if you provide more detail, there may be other members that can respond to you. Wishing you the best
6/17/2019, IDC, Left, 6cm+, Stage IIIC, Grade 3, ER-/PR-, HER2-
6/24/2019 AC + T (Taxol)
4/6/2020 Xeloda (capecitabine)
Whole-breast: Breast, Lymph nodes, Chest wall
Log in to post a reply
Jul 15, 2021 09:07PM
Jul 15, 2021 09:09PM
p_ahmadi, I'm sorry you find yourself here.
yes , change of markers is actually not that uncommon, with a loss of markers being more common than a gain of markers.
We have a subforum specifically for Stage IV triple neg. I'm going to link you directly to p. 93 of that forum because on that page, 4th post from the top is where I've listed all the treatments for us.
with bone mets, radiation to the area, either standard or SBRT may be offered
You will also need to start a bone strengthening medication, either a bisphosphonate such as Zometa/zoledronic acid or a monoclonal antibody such Xgeva/denosumab.
We also have bone mets forum which you will want to have a look at. https://community.breastcancer.org/forum/8/topics/...
Also you can look at the National Comprehensive Cancer Network guide to metastatic breast cancer https://www.nccn.org/patients/guidelines/content/P...
I take weekends off
Initial dx at 50. Seriously?? “Sometimes the future changes quickly and completely and we’re left with only the choice of what to do next." blog: Never Tell Me the Odds
12/2017, IDC, Left, 1cm, Stage IA, Grade 3, 0/5 nodes, ER-/PR-, HER2- (IHC)
12/12/2017 Lumpectomy: Left; Lymph node removal: Sentinel
2/14/2018 AC + T (Taxol)
8/13/2018 Whole-breast: Breast
2/2020, IDC, Stage IV, metastasized to liver/lungs, Grade 3, ER-/PR-, HER2-
3/18/2020 Taxol (paclitaxel)
3/19/2020 Tecentriq (atezolizumab)
11/26/2020 Abraxane (albumin-bound or nab-paclitaxel)
12/9/2020, IDC, Right, Stage IV, metastasized to lungs, Grade 3, ER+/PR-, HER2- (IHC)
12/16/2020 Femara (letrozole)
1/28/2021, IDC, Left, Stage IV, metastasized to bone
3/3/2021 External: Bone